By Art Golab and Michael Sandler | June 30, 2015 Genentech, the maker of Avastin and other expensive cancer drugs, paid physicians and teaching hospitals more than any other drug or device company in 2014, according to a new round of data published Tuesday on the CMS’ Open Payments website. The data reveal payments made for research, gifts, speaking fees, meals […]
All News
BY BRAD PERRIELLO Titan Medical (CVE:TMD) today priced an 8.9-million-share offering at about 65¢ per share, saying it plans to use the proceeds to continue developing its Sport robot-assisted surgery platform. Toronto-based Titan said it could gross about $5.8 million (C$8 million) from the offering, which is slated to close Feb 12. Each unit of the offering […]
Factors propelling the growth of the spinal trauma devices market in Asia Pacific are rising disposable income, high affordability of expensive medical treatments, and rising health care awareness among the people. This press release was orginally distributed by SBWire Albany, NY — (SBWIRE) — 02/09/2016 — This report on the spinal trauma devices market studies the […]
AUSTIN, Texas, Feb. 09, 2016 (GLOBE NEWSWIRE) — LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that NEUROSURGERY® has published a peer-reviewed article that evaluated the cost-effectiveness of two-level cervical Total Disc Replacement (cTDR) […]
MONTPELLIER, France, Feb. 10, 2016 (GLOBE NEWSWIRE) — MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, announced that it will showcase its ROSA™ Brain robotic surgery system at the Annual Meeting & Courses of the American Clinical Neurophysiology Society (ACNS), held in Orlando, FL (United States) […]
The U.S. Senate Committee on Health, Education, Labor and Pensions favorably reported a measure today that would reduce regulatory hurdles for the approval of medical devices. The “FDA Device Accountability Act of 2015” (S. 1622), sponsored by Sens. Richard Burr, R-N.C.; and Al Franken, D-Minn., and co-sponsored by Mark Kirk, R-Ill., is intended to ensure the “least burdensome means” of evaluating […]
SAN JOSE, Calif., Feb. 11, 2016 — (Healthcare Sales & Marketing Network) — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced the publication of two economic studies showing the cost […]
Strain D, et al. J Long Term Eff Med Implants. 2015. Show full citation Abstract We investigated the efficacy and cost effectiveness of the KineSpring System in the Spanish healthcare system, as compared to other standard treatments methods. Cost-utility ratios were calculated using derived cost data and we calculated quality-adjusted life years (QALYs) gained for […]
By: Ron Carucci Despite the huge impact executives can have on their organizations, failure rates remain high. Prescriptions for what to do continue to fall short. So we wondered: If we closely studied the executives who succeed in top jobs once appointed, could we identify distinguishing features that set them apart and defined their success? As part […]
In an attempt to expand its product portfolio that addresses pain therapeutic solutions, Medtronic plc MDT recently launched its OsteoCool radiofrequency (RF) Ablation System in the U.S. market, subsequent to the receipt of the FDA 510(k) approval for the same. The OsteoCool System is designed to treat cancer patients suffering from painful spinal metastasis. Incidentally, the OsteoCool […]
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1